| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.91 | 0.003 | 0.91 | Epidermal growth factor receptor kinase inhibitor | 0.716 0.004 CID_154700041 | ||
| 0.843 | 0.002 | 0.843 | ErbB-1 antagonist | 0.757 0.003 CID_154700041 | ||
| 0.795 | 0.003 | 0.795 | Epidermal growth factor antagonist | 0.546 0.004 CID_154700041 | ||
| 0.754 | 0.005 | 0.754 | Growth factor antagonist | 0.545 0.009 CID_154700041 | ||
| 0.677 | 0.004 | 0.677 | ErbB-2 antagonist | 0.406 0.004 CID_154700041 | ||
| 0.636 | 0.013 | 0.798 | Angiogenesis inhibitor | 0.798 0.005 CID_154700041 | CID_154700041 | |
| 0.61 | 0.018 | 0.61 | Aldehyde oxidase inhibitor | |||
| 0.574 | 0.005 | 0.574 | Vascular endothelial growth factor antagonist | 0.308 0.021 CID_154700041 | ||
| 0.55 | 0.006 | 0.55 | Vascular endothelial growth factor 2 antagonist | 0.234 0.028 CID_154700041 | ||
| 0.505 | 0.005 | 0.505 | RET inhibitor | 0.231 0.035 CID_154700041 | ||
| 0.475 | 0.007 | 0.475 | Src kinase inhibitor | 0.231 0.041 CID_154700041 | ||
| 0.469 | 0.004 | 0.469 | Ephrin antagonist | 0.282 0.011 CID_154700041 | ||
| 0.459 | 0.006 | 0.459 | MAP kinase kinase 2 inhibitor | |||
| 0.451 | 0.005 | 0.451 | c-Src kinase inhibitor | 0.23 0.028 CID_154700041 | ||
| 0.422 | 0.01 | 0.422 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.231 0.051 CID_154700041 | ||
| 0.417 | 0.009 | 0.417 | Vascular endothelial growth factor 3 antagonist | 0.224 0.034 CID_154700041 | ||
| 0.402 | 0.004 | 0.402 | MAP kinase kinase inhibitor | 0.268 0.013 CID_154700041 | ||
| 0.401 | 0.006 | 0.401 | Platelet activating factor beta antagonist | 0.218 0.021 CID_154700041 | ||
| 0.414 | 0.026 | 0.414 | Tyrosine kinase inhibitor | 0.137 0.097 CID_154700041 | ||
| 0.398 | 0.019 | 0.398 | Platelet aggregation inhibitor | 0.238 0.057 CID_154700041 | ||
| 0.382 | 0.012 | 0.382 | DNA methylase inhibitor | |||
| 0.36 | 0.005 | 0.36 | ErbB-4 antagonist | 0.242 0.008 CID_154700041 | ||
| 0.356 | 0.004 | 0.356 | EphB4 antagonist | 0.088 0.021 CID_154700041 | ||
| 0.349 | 0.008 | 0.349 | Platelet activating factor antagonist | 0.172 0.035 CID_154700041 | ||
| 0.371 | 0.035 | 0.371 | DNA damaging | 0.21 0.108 CID_154700041 | ||
| 0.33 | 0.005 | 0.33 | Raf kinase C inhibitor | 0.143 0.016 CID_154700041 | ||
| 0.327 | 0.004 | 0.327 | ErbB-3 antagonist | 0.261 0.005 CID_154700041 | ||
| 0.422 | 0.103 | 0.422 | Apoptosis agonist | 0.295 0.175 CID_154700041 | ||
| 0.325 | 0.009 | 0.325 | Protein kinase (CK2) alpha inhibitor | |||
| 0.322 | 0.016 | 0.322 | Protein-tyrosine kinase Lyn inhibitor | 0.147 0.067 CID_154700041 | ||
| 0.317 | 0.013 | 0.317 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.148 0.075 CID_154700041 | ||
| 0.307 | 0.004 | 0.307 | EphA2 antagonist | 0.266 0.005 CID_154700041 | ||
| 0.323 | 0.019 | 0.323 | DNA methyltransferase I inhibitor | |||
| 0.32 | 0.027 | 0.32 | CDC-like kinase 4 inhibitor | 0.159 0.093 CID_154700041 | ||
| 0.295 | 0.012 | 0.295 | Vascular endothelial growth factor 1 antagonist | 0.113 0.058 CID_154700041 | ||
| 0.317 | 0.035 | 0.317 | Clk dual-specificity kinase inhibitor | 0.133 0.131 CID_154700041 | ||
| 0.317 | 0.047 | 0.317 | Dyrk kinase inhibitor | |||
| 0.302 | 0.05 | 0.302 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.293 | 0.042 | 0.293 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.356 | 0.11 | 0.356 | 5 Hydroxytryptamine release inhibitor | |||
| 0.244 | 0.008 | 0.244 | MAP kinase kinase 5 inhibitor | 0.212 0.021 CID_154700041 | ||
| 0.244 | 0.012 | 0.244 | Protein kinase (CK2) inhibitor | |||
| 0.227 | 0.002 | 0.227 | Fructose-1,6-bisphosphatase inhibitor | 0.108 0.004 CID_154700041 | ||
| 0.229 | 0.011 | 0.255 | Breast cancer-resistant protein inhibitor | 0.255 0.009 CID_154700041 | CID_154700041 | |
| 0.244 | 0.026 | 0.244 | Lck kinase inhibitor | 0.114 0.09 CID_154700041 | ||
| 0.218 | 0.004 | 0.218 | MAP kinase kinase 1 inhibitor | 0.122 0.033 CID_154700041 | ||
| 0.267 | 0.054 | 0.267 | Antimitotic | 0.233 0.067 CID_154700041 | ||
| 0.251 | 0.038 | 0.251 | LIM domain kinase 1 inhibitor | |||
| 0.218 | 0.015 | 0.218 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | |||
| 0.277 | 0.079 | 0.277 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.199 | 0.017 | 0.199 | Platelet activating factor alpha antagonist | 0.087 0.071 CID_154700041 | ||
| 0.213 | 0.034 | 0.213 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.184 | 0.014 | 0.184 | Raf kinase inhibitor | |||
| 0.177 | 0.012 | 0.177 | Platelet growth factor antagonist | 0.081 0.056 CID_154700041 | ||
| 0.188 | 0.023 | 0.188 | Cyclooxygenase 3 inhibitor | |||
| 0.218 | 0.057 | 0.218 | CDC-like kinase 2 inhibitor | |||
| 0.194 | 0.033 | 0.194 | Aurora-B kinase inhibitor | |||
| 0.19 | 0.031 | 0.19 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.188 | 0.031 | 0.188 | Abl kinase inhibitor | |||
| 0.22 | 0.065 | 0.22 | Death-associated protein kinase 3 inhibitor | |||
| 0.222 | 0.073 | 0.222 | EphB2 antagonist | |||
| 0.156 | 0.01 | 0.156 | Purinergic P2X2 antagonist | 0.141 0.014 CID_154700041 | ||
| 0.157 | 0.013 | 0.157 | Raf kinase B inhibitor | |||
| 0.152 | 0.01 | 0.175 | Fibroblast growth factor 2 antagonist | 0.175 0.008 CID_154700041 | CID_154700041 | |
| 0.215 | 0.079 | 0.262 | RNA-directed DNA polymerase inhibitor | 0.262 0.043 CID_154700041 | CID_154700041 | |
| 0.203 | 0.069 | 0.203 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.165 | 0.032 | 0.165 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.133 | 0.005 | 0.133 | Heat shock protein 90 beta antagonist | |||
| 0.152 | 0.024 | 0.247 | Multidrug resistance-associated protein 1 inhibitor | 0.247 0.005 CID_154700041 | CID_154700041 | |
| 0.175 | 0.052 | 0.175 | CDC-like kinase 1 inhibitor | |||
| 0.17 | 0.049 | 0.17 | Tubulin antagonist | 0.104 0.098 CID_154700041 | ||
| 0.147 | 0.034 | 0.147 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.244 | 0.132 | 0.244 | Transcription factor NF kappa B inhibitor | |||
| 0.166 | 0.056 | 0.166 | Activin receptor-like kinase 2 inhibitor | |||
| 0.167 | 0.058 | 0.167 | Heat shock protein 90 antagonist | |||
| 0.233 | 0.128 | 0.233 | Caspase 3 stimulant | |||
| 0.149 | 0.051 | 0.149 | Aurora-C kinase inhibitor | |||
| 0.122 | 0.024 | 0.122 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.118 | 0.028 | 0.118 | Bcr-Abl kinase inhibitor | |||
| 0.172 | 0.084 | 0.172 | TRKC antagonist | |||
| 0.134 | 0.047 | 0.134 | Aurora-A kinase inhibitor | |||
| 0.126 | 0.04 | 0.128 | Fibroblast growth factor 1 antagonist | 0.128 0.039 CID_154700041 | CID_154700041 | |
| 0.177 | 0.091 | 0.177 | Growth factor agonist | |||
| 0.123 | 0.039 | 0.123 | CDC-like kinase 3 inhibitor | |||
| 0.085 | 0.003 | 0.085 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.028 0.009 CID_154700041 | ||
| 0.144 | 0.071 | 0.144 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.161 | 0.1 | 0.161 | Amyloid beta aggregation inhibitor | |||
| 0.088 | 0.028 | 0.088 | MAP kinase kinase 7 inhibitor | |||
| 0.099 | 0.042 | 0.099 | TIE antagonist | |||
| 0.097 | 0.041 | 0.097 | TIE-2 antagonist | |||
| 0.078 | 0.024 | 0.078 | Phosphodiesterase 1B inhibitor | |||
| 0.162 | 0.109 | 0.162 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.136 | 0.083 | 0.136 | MAP3K9 inhibitor | |||
| 0.14 | 0.088 | 0.14 | GABA C receptor rho-2 antagonist | |||
| 0.061 | 0.011 | 0.061 | Phosphoglycerate kinase inhibitor | 0.057 0.012 CID_154700041 | ||
| 0.097 | 0.049 | 0.097 | Insulin growth factor antagonist | |||
| 0.107 | 0.059 | 0.107 | Check point kinase 2 inhibitor | |||
| 0.103 | 0.057 | 0.103 | Xanthine oxidase inhibitor | |||
| 0.127 | 0.084 | 0.127 | CC chemokine 6 receptor antagonist | |||
| 0.079 | 0.037 | 0.079 | ZAP-70 protein tyrosine kinase inhibitor | |||
| 0.085 | 0.043 | 0.085 | Keratolytic | |||
| 0.047 | 0.007 | 0.047 | Estrogen-related receptor beta antagonist | |||
| 0.093 | 0.053 | 0.093 | Phosphodiesterase I inhibitor | |||
| 0.175 | 0.139 | 0.175 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.087 | 0.052 | 0.087 | Insulin like growth factor 1 antagonist | |||
| 0.118 | 0.083 | 0.118 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.086 | 0.052 | 0.086 | ALK inhibitor | |||
| 0.075 | 0.044 | 0.075 | Syk tyrosine kinase inhibitor | |||
| 0.098 | 0.068 | 0.098 | Estrogen receptor beta antagonist | |||
| 0.079 | 0.049 | 0.079 | MAP kinase 7 inhibitor | |||
| 0.044 | 0.014 | 0.044 | Purinergic P2X3 antagonist | |||
| 0.083 | 0.054 | 0.083 | Transforming growth factor beta 3 antagonist | |||
| 0.096 | 0.068 | 0.096 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.072 | 0.046 | 0.072 | Glutamate (mGluR group I) antagonist | |||
| 0.111 | 0.085 | 0.111 | TRKB antagonist | |||
| 0.076 | 0.05 | 0.076 | Vanilloid antagonist | |||
| 0.106 | 0.085 | 0.106 | Estrogen antagonist | |||
| 0.081 | 0.06 | 0.081 | Thioredoxin reductase inhibitor | |||
| 0.212 | 0.193 | 0.212 | GABA C receptor rho-3 antagonist | |||
| 0.051 | 0.034 | 0.051 | Antiviral (Hepatitis D) | |||
| 0.08 | 0.063 | 0.08 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.064 | 0.049 | 0.064 | Vanilloid 1 antagonist | |||
| 0.103 | 0.089 | 0.103 | Interleukin 8 antagonist | |||
| 0.084 | 0.07 | 0.084 | Hepatocyte growth factor antagonist | |||
| 0.073 | 0.06 | 0.073 | Macrophage migration inhibitory factor inhibitor | |||
| 0.248 | 0.235 | 0.248 | MAP kinase 1 inhibitor | |||
| 0.056 | 0.044 | 0.056 | CDK9/cyclin T1 inhibitor | |||
| 0.04 | 0.03 | 0.04 | Thymidine kinase inhibitor | 0.037 0.036 CID_154700041 | ||
| 0.255 | 0.247 | 0.255 | Caspase 9 stimulant | |||
| 0.027 | 0.021 | 0.027 | DNA polymerase III inhibitor | |||
| 0.044 | 0.038 | 0.044 | Proto-oncogene tyrosine-protein kinase Met inhibitor | |||
| 0.131 | 0.126 | 0.131 | Tumour necrosis factor antagonist | |||
| 0.043 | 0.038 | 0.043 | Glutamate (mGluR5) antagonist | |||
| 0.064 | 0.06 | 0.064 | Macrophage colony-stimulating factor 1 receptor antagonist | |||
| 0.074 | 0.071 | 0.074 | AXL receptor tyrosine kinase inhibitor | |||
| 0.029 | 0.027 | 0.029 | Estrogen-related receptor alpha antagonist | |||
| 0.047 | 0.045 | 0.047 | Alpha tubulin antagonist | |||
| 0.067 | 0.065 | 0.067 | Glutamate (mGluR) antagonist | |||
| 0.123 | 0.122 | 0.123 | Heat shock protein 90 alpha antagonist | |||
| 0.021 | 0.02 | 0.021 | Adenosine A1 receptor agonist | |||
| 0.032 | 0.067 | 0.046 | Dihydrofolate reductase inhibitor | 0.046 0.024 CID_154700041 | CID_154700041 | |
| 0.033 | 0.079 | 0.07 | H+/K+-transporting ATPase inhibitor | 0.07 0.017 CID_154700041 | CID_154700041 | |
| 0.023 | 0.07 | 0.064 | Estrogen agonist | 0.064 0.028 CID_154700041 | CID_154700041 | |
| 0.017 | 0.117 | 0.028 | Toll-Like receptor 4 agonist | 0.028 0.014 CID_154700041 | CID_154700041 | |
| 0.039 | 0.156 | 0.06 | MAP kinase kinase 10 inhibitor | 0.06 0.059 CID_154700041 | CID_154700041 | |
| 0.025 | 0.191 | 0.065 | Factor IXa inhibitor | 0.065 0.023 CID_154700041 | CID_154700041 | |
| 0.065 | 0.245 | 0.194 | Dual specificity phosphatase 3 inhibitor | 0.194 0.064 CID_154700041 | CID_154700041 | |
| 0.053 | 0.272 | 0.277 | Angiogenesis stimulant | 0.277 0.058 CID_154700041 | CID_154700041 | |
| 0.049 | 0.324 | 0.162 | Dual specificity phosphatase inhibitor | 0.162 0.082 CID_154700041 | CID_154700041 | |
| 0.003 | 0.303 | 0.02 | Estrone sulfatase inhibitor | 0.02 0.017 CID_154700041 | CID_154700041 | |
| 0.027 | 0.382 | 0.126 | Protein-tyrosine phosphatase inhibitor | 0.126 0.106 CID_154700041 | CID_154700041 | |
| 0.004 | 0.46 | 0.181 | Cholecystokinin A agonist | 0.181 0.003 CID_154700041 | CID_154700041 | |
| 0.004 | 0.463 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.024 CID_154700041 | CID_154700041 | |
| 0.007 | 0.482 | 0.056 | Selectin antagonist | 0.056 0.053 CID_154700041 | CID_154700041 | |
| 0.01 | 0.523 | 0.372 | Cholecystokinin B agonist | 0.372 0.003 CID_154700041 | CID_154700041 | |
| 0.003 | 0.526 | 0.206 | Cholecystokinin agonist | 0.206 0.003 CID_154700041 | CID_154700041 | |
| 0.005 | 0.587 | 0.061 | NMDA 2B receptor antagonist | 0.061 0.03 CID_154700041 | CID_154700041 | |
| 0.011 | 0.669 | 0.217 | Anticoagulant | 0.217 0.047 CID_154700041 | CID_154700041 | |
| 0.002 | 0.873 | 0.058 | Cholecystokinin A antagonist | 0.058 0.017 CID_154700041 | CID_154700041 | |
| 0.002 | 0.888 | 0.028 | Cholecystokinin B antagonist | 0.028 0.023 CID_154700041 | CID_154700041 | |
| 0.003 | 0.893 | 0.035 | Cholecystokinin antagonist | 0.035 0.032 CID_154700041 | CID_154700041 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |